Polish Healthtech Startup MY OVU Launches Temperature-Tracking Device for Fertility Monitoring

The article interviews Dr. Aleksandra Staniszewska, CEO of MY OVU, about the company’s new medical device that continuously monitors body temperature to provide more accurate data for women’s health, especially during early morning hours. The device is wireless, measures temperature every four minutes, and is positioned as a superior alternative to traditional fertility calendar apps.

Spanish AgriTech Startup Grodi Brings Autonomous Robotics to Mediterranean Greenhouse Farming

Grodi is an AgriTech startup that creates proprietary autonomous robots, artificial vision systems and advanced data analysis tools to monitor the health and yield of crops. The solution is adapted to Mediterranean greenhouse environments, detects risks early, generates geolocated maps and helps reduce losses, optimise resources and improve agricultural profitability.

Mistral AI Unveils €830M Infrastructure Expansion to Build European AI Compute Powerhouse

Mistral AI, a French AI startup, unveiled a major infrastructure push to deliver 1 GW of European AI compute by 2030. The plan includes regional inference endpoints, a premium SLA‑backed tier, and long‑term compute contracts with European enterprises, backed by €830 million of debt financing. The move positions Mistral as a sovereign AI infrastructure provider, complementing its partnership with Microsoft and its open‑model hosting strategy.

Austrian Startup Efferon Expands Blood-Purification Technology After Securing Paediatric Approval in Europe

Austrian startup Efferon, founded in 2016, creates blood‑purification cartridges that remove bacterial toxins and inflammatory mediators to treat sepsis. After receiving European CE MDR approval for its adult device in 2024 and paediatric certification in 2026, the devices have been used in over 25,000 treatments in 44 countries, generating more than €1 million in revenue. Efferon is now pursuing US regulatory pathways, expanding into China, and developing an outpatient solution for post‑sepsis and chronic inflammation.